Overview of clinicopathologic features of ALK-rearranged lung adenocarcinoma and current diagnostic testing for ALK rearrangement

Por Kim, Hyojin, Chung, Jin-Haeng
Publicado no Transl Lung Cancer Res (2015)

Chitinase-3-like-1/YKL-40 as marker of circulating tumor cells

Por Hamilton, Gerhard, Rath, Barbara, Burghuber, Otto
Publicado no Transl Lung Cancer Res (2015)

Lung cancer in HIV-infected patients in the combination antiretroviral treatment era

Por Moltó, José, Moran, Teresa, Sirera, Guillem, Clotet, Bonaventura
Publicado no Transl Lung Cancer Res (2015)

Is epidermal growth factor receptor tyrosine kinase inhibitor in combination with cytotoxic chemotherapy a better treatment option for patients with EGFR-mutated non-small-cell lun...

Por Takahashi, Kosuke, Saito, Hiroshi
Publicado no Transl Lung Cancer Res (2016)

Circulating tumor cells versus circulating tumor DNA in lung cancer—which one will win?

Por Calabuig-Fariñas, Silvia, Jantus-Lewintre, Eloísa, Herreros-Pomares, Alejandro, Camps, Carlos
Publicado no Transl Lung Cancer Res (2016)

Pulmonary ground-glass opacity: computed tomography features, histopathology and molecular pathology

Por Gao, Jian-Wei, Rizzo, Stefania, Ma, Li-Hong, Qiu, Xiang-Yu, Warth, Arne, Seki, Nobuhiko, Hasegawa, Mizue, Zou, Jia-Wei, Li, Qian, Femia, Marco, Lv, Tang-Feng, Song, Yong
Publicado no Transl Lung Cancer Res (2017)

In vitro experimental models of mesothelioma revisited

Por Singh, Anand, Pruett, Nathanael, Hoang, Chuong D.
Publicado no Transl Lung Cancer Res (2017)

The role of Imaging and Radiation Oncology Core for precision medicine era of clinical trial

Por Xiao, Ying, Rosen, Mark
Publicado no Transl Lung Cancer Res (2017)

Proton therapy for thoracic reirradiation of non-small cell lung cancer

Por Chao, Hann-Hsiang, Berman, Abigail T.
Publicado no Transl Lung Cancer Res (2018)

The epidemiology of lung cancer

Por de Groot, Patricia M., Wu, Carol C., Carter, Brett W., Munden, Reginald F.
Publicado no Transl Lung Cancer Res (2018)

Update on screening for lung cancer

Por Arenberg, Douglas
Publicado no Transl Lung Cancer Res (2019)

PACIFIC: shifting tides in the treatment of locally advanced non-small cell lung cancer

Por Bang, Andrew, Schoenfeld, Jonathan D., Sun, Alexander Y.
Publicado no Transl Lung Cancer Res (2019)

KRAS mutant NSCLC, a new opportunity for the synthetic lethality therapeutic approach

Por de Castro Carpeño, Javier, Belda-Iniesta, Cristóbal
Publicado no Transl Lung Cancer Res (2013)

Treating acquired resistance to EGFR-tyrosine kinase inhibitors:still a work in progress

Por Pennell, Nathan A.
Publicado no Transl Lung Cancer Res (2012)

Are three doses of stereotactic ablative radiotherapy (SABR) more effective than 30 doses of conventional radiotherapy?

Por Simeonova, Anna O., Fleckenstein, Katharina, Wertz, Hansjörg, Frauenfeld, Anian, Boda-Heggemann, Judit, Lohr, Frank, Wenz, Frederik
Publicado no Transl Lung Cancer Res (2012)

Angiogenesis in cancer: Anti-VEGF escape mechanisms

Por Prager, Gerald W., Poettler, Marina, Unseld, Matthias, Zielinski, Christoph C.
Publicado no Transl Lung Cancer Res (2012)

Implementation of lung cancer screening: promises and hurdles

Por Prosch, Helmut
Publicado no Transl Lung Cancer Res (2014)

Targeted therapy for non-small cell lung cancer: current standards and the promise of the future

Por Chan, Bryan A., Hughes, Brett G.M.
Publicado no Transl Lung Cancer Res (2015)

The role of interleukin-6 in malignant mesothelioma

Por Abdul Rahim, Siti N., Ho, Gwo Y., Coward, Jermaine I.G.
Publicado no Transl Lung Cancer Res (2015)

Adjuvant chemotherapy of completely resected early stage non-small cell lung cancer (NSCLC)

Por Liang, Ying, Wakelee, Heather A.
Publicado no Transl Lung Cancer Res (2013)